Atlas Trials

A Study in Subjects With Moderate Atopic Dermatitis

Clinical trial NCT03175354 · COMPLETED

Trial details

NCT number
NCT03175354
Sponsor
Ralexar Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic DermatitisEczema, Atopic
Start date
2017-04-26
Primary completion
2018-06-29
Enrollment
209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.